Evidence map›Paper›PMID 30042399›Full record

ArticleScientific reports2018

Chloroquine exposure triggers distinct cellular responses in sensitive versus resistant Plasmodium falciparum parasites.

Sarah J Reiling, Georg Krohne, Oliver Friedrich, Timothy G Geary, Petra Rohrbach

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Arylmethylamino steroid compound 1o interferes withAntimicrobial agents and chemotherapy · 2025
    Article
  2. PfMDR1 Transport Rates Assessed in Intact IsolatedPharmaceuticals (Basel, Switzerland) · 2022
    Article
  3. Review
  4. Review
  5. The host targeting effect of chloroquine in malaria.Current opinion in immunology · 2020
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Sarah J ReilingInstitute of Parasitology, McGill University, Ste. Anne de Bellevue (Montréal), Québec, Canada.
Georg KrohneTheodor Boveri Institute, Biocenter, University of Würzburg, Würzburg, Germany.
Oliver FriedrichInstitute of Medical Biotechnology, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany.
Timothy G GearyInstitute of Parasitology, McGill University, Ste. Anne de Bellevue (Montréal), Québec, Canada.
Petra RohrbachInstitute of Parasitology, McGill University, Ste. Anne de Bellevue (Montréal), Québec, Canada. petra.rohrbach@mcgill.ca.
McGill University · CAFriedrich-Alexander-Universität Erlangen-Nürnberg · DEUniversity of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chloroquine (CQ) treatment failure in Plasmodium falciparum parasites has been documented for decades, but the pharmacological explanation of this phenotype is not fully understood. Current concepts attribute CQ resistance to reduced accumulation of the drug at a given external CQ concentration ([CQ]

Indexed as

AnimalsChloroquineDrug ResistanceHumansMalaria, FalciparumMembrane Transport ProteinsParasitic Sensitivity TestsPlasmodium falciparumProtozoan ProteinsChloroquineMembrane Transport ProteinsProtozoan Proteins

Identifiers

PMID30042399
PMCPMC6057915
OpenAlexW2883535797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.